132 related articles for article (PubMed ID: 1988776)
1. Nocturnal growth hormone secretion does not affect diurnal variations in arginine and glucose-stimulated insulin secretion.
Lee A; Bray GA; Kletzky O
Metabolism; 1991 Feb; 40(2):181-6. PubMed ID: 1988776
[TBL] [Abstract][Full Text] [Related]
2. Suppression of sleep-induced growth hormone secretion by anticholinergic agent abolishes dawn phenomenon.
Davidson MB; Harris MD; Ziel FH; Rosenberg CS
Diabetes; 1988 Feb; 37(2):166-71. PubMed ID: 3391341
[TBL] [Abstract][Full Text] [Related]
3. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity.
Maccario M; Grottoli S; Razzore P; Procopio M; Oleandri SE; Ciccarelli E; Camanni F; Ghigo E
Eur J Endocrinol; 1996 Aug; 135(2):205-10. PubMed ID: 8810734
[TBL] [Abstract][Full Text] [Related]
4. Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects.
Lee A; Ader M; Bray GA; Bergman RN
Diabetes; 1992 Jun; 41(6):750-9. PubMed ID: 1587401
[TBL] [Abstract][Full Text] [Related]
5. Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism.
Mendelson WB; Sitaram N; Wyatt RJ; Gillin JC; Jacobs LS
J Clin Invest; 1978 Jun; 61(6):1683-90. PubMed ID: 659621
[TBL] [Abstract][Full Text] [Related]
6. Nocturnal elevation of glucose levels during fasting in noninsulin-dependent diabetes.
Shapiro ET; Polonsky KS; Copinschi G; Bosson D; Tillil H; Blackman J; Lewis G; Van Cauter E
J Clin Endocrinol Metab; 1991 Feb; 72(2):444-54. PubMed ID: 1991813
[TBL] [Abstract][Full Text] [Related]
7. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep.
Van Cauter E; Blackman JD; Roland D; Spire JP; Refetoff S; Polonsky KS
J Clin Invest; 1991 Sep; 88(3):934-42. PubMed ID: 1885778
[TBL] [Abstract][Full Text] [Related]
8. Nocturnal monitoring of growth hormone, insulin, C-peptide, and glucose in patients with acromegaly.
Tsai JS; Zorrilla LL; Jacob KK; Rosenberg S; Marcus DL
Am J Med Sci; 1996 Jun; 311(6):281-5. PubMed ID: 8659555
[TBL] [Abstract][Full Text] [Related]
9. Diurnal variation in response to intravenous glucose.
Whichelow MJ; Sturge RA; Keen H; Jarrett RJ; Stimmler L; Grainger S
Br Med J; 1974 Mar; 1(5906):488-91. PubMed ID: 4817160
[TBL] [Abstract][Full Text] [Related]
10. Methscopolamine bromide blocks hypothalamic-stimulated release of growth hormone in ewes.
Daniel JA; Thomas MG; Powell MR; Keisler DH
J Anim Sci; 1997 May; 75(5):1359-62. PubMed ID: 9159285
[TBL] [Abstract][Full Text] [Related]
11. Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man.
Imura H; Kato Y; Ikeda M; Morimoto M; Yawata M
J Clin Invest; 1971 May; 50(5):1069-79. PubMed ID: 4928263
[TBL] [Abstract][Full Text] [Related]
12. Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity.
Van Cauter EV; Polonsky KS; Blackman JD; Roland D; Sturis J; Byrne MM; Scheen AJ
J Clin Endocrinol Metab; 1994 Dec; 79(6):1797-805. PubMed ID: 7989487
[TBL] [Abstract][Full Text] [Related]
13. Diurnal variations in cardiovascular function and glucose regulation in normotensive humans.
Biston P; Van Cauter E; Ofek G; Linkowski P; Polonsky KS; Degaute JP
Hypertension; 1996 Nov; 28(5):863-71. PubMed ID: 8901836
[TBL] [Abstract][Full Text] [Related]
14. Diurnal variation on oral glucose tolerance: insulin and growth hormone changes with special reference to women taking oral contraceptives.
Oakley NW; Monier D; Wynn V
Diabetologia; 1973 Jun; 9(3):235-8. PubMed ID: 4716490
[TBL] [Abstract][Full Text] [Related]
15. [Diurnal variation of glucose tolerance and insulin secretion in man (author's transl)].
Grabner W; Matzkies F; Prestele H; Rose A; Daniel U; Phillip J; Fischer K
Klin Wochenschr; 1975 Aug; 53(16):773-8. PubMed ID: 1165623
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone response to insulin and to arginine in patients with familial hypercholesterolaemia.
Muggeo M; Tiengo A; Fedele D; Crepaldi G
Atherosclerosis; 1975; 22(3):543-50. PubMed ID: 1201152
[TBL] [Abstract][Full Text] [Related]
17. Reduced growth hormone secretion improves insulin sensitivity in adolescent girls with type 1 diabetes.
Aman J; Kroon M; Karlsson I; Jones I; Hagenäs L
Acta Paediatr; 1996 Jan; 85(1):31-7. PubMed ID: 8834976
[TBL] [Abstract][Full Text] [Related]
18. Insulin and growth hormone secretion stimulated by intravenous administration of arginine in the low insulin responders (prediabetes?).
Toyota T; Kudo M; Goto Y
Tohoku J Exp Med; 1977 Dec; 123(4):359-64. PubMed ID: 605445
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
Leblanc H; Anderson JR; Sigel MB; Yen SS
J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
[TBL] [Abstract][Full Text] [Related]
20. Diurnal variation in the effects of insulin on blood glucose, plasma non-esterified fatty acids and growth hormone.
Gibson T; Stimmler L; Jarrett RJ; Rutland P; Shiu M
Diabetologia; 1975 Feb; 11(1):83-8. PubMed ID: 1170119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
